AxSpA duration, per year
|
1.187
|
1.089–1.294
|
0.000
|
1.180
|
1.086–1.283
|
0.000
|
1.188
|
1.090–1.295
|
0.000
|
1.190
|
1.096–1.293
|
0.000
|
ESR, per mm/h
|
1.003
|
0.981–1.025
|
0.794
|
1.003
|
0.982–1.025
|
0.755
|
1.001
|
0.981–1.022
|
0.905
|
1.003
|
0.982–1.024
|
0.781
|
CRP, per mg/l
|
1.038
|
0.999–1.079
|
0.058
|
1.018
|
0.991–1.046
|
0.194
|
1.025
|
0.987–1.065
|
0.196
|
1.008
|
0.981–1.036
|
0.576
|
Total back pain, per score
|
1.428
|
1.040–1.962
|
0.028
|
1.246
|
0.975–1.591
|
0.078
|
1.315
|
0.959–1.803
|
0.089
|
1.166
|
0.916–1.484
|
0.212
|
PGA of disease activity, per score
|
1.040
|
0.784–1.380
|
0.786
|
0.975
|
0.746–1.275
|
0.856
|
1.023
|
0.780–1.342
|
0.868
|
0.970
|
0.751–1.252
|
0.815
|
Pain and swelling of peripheral arthritis, per score
|
1.517
|
0.795–2.897
|
0.207
|
1.356
|
0.725–2.534
|
0.341
|
1.858
|
0.978–3.532
|
0.059
|
1.657
|
0.890–3.084
|
0.111
|
Duration of morning stiffness, per score
|
0.723
|
0.519–1.008
|
0.056
|
0.682
|
0.494–0.942
|
0.020
|
0.836
|
0.607–1.150
|
0.271
|
0.792
|
0.581–1.079
|
0.139
|
ASDAS, per score
|
0.492
|
0.179–1.354
|
0.170
|
NA
|
NA
|
NA
|
0.526
|
0.194–1.429
|
0.208
|
NA
|
NA
|
NA
|
BASFI, per score
|
3.837
|
2.263–6.506
|
0.000
|
3.800
|
2.250–6.417
|
0.000
|
3.092
|
1.896–5.044
|
0.000
|
3.034
|
1.870–4.922
|
0.000
|
Ever use of biologic DMARDs, vs never
|
≥ 12 months
|
1.051
|
0.308–3.581
|
0.937
|
1.144
|
0.337–3.885
|
0.829
|
1.425
|
0.417–4.872
|
0.572
|
1.414
|
0.421–4.754
|
0.575
|
≤ 12 months
|
0.961
|
0.333–2.778
|
0.942
|
1.098
|
0.385–3.132
|
0.861
|
0.971
|
0.329–2.866
|
0.958
|
1.020
|
0.357–2.916
|
0.971
|
≤ 6 months
|
1.999
|
0.806–4.962
|
0.135
|
1.830
|
0.745–4.495
|
0.188
|
2.461
|
0.976–6.204
|
0.056
|
2.128
|
0.869–5.211
|
0.099
|
Never
|
NA
|
NA
|
NA
|
NA
|
NA
|
NA
|
NA
|
NA
|
NA
|
NA
|
NA
|
NA
|
MSU crystallization positive, vs negative
|
Left sacroiliac joint
|
0.895
|
0.391–2.049
|
0.794
|
NA
|
NA
|
NA
|
NA
|
NA
|
NA
|
NA
|
NA
|
NA
|
Right sacroiliac joint
|
NA
|
NA
|
NA
|
NA
|
NA
|
NA
|
1.291
|
0.542–3.075
|
0.565
|
NA
|
NA
|
NA
|
Volume of MSU crystallization, per cm3
|
Left sacroiliac joint
|
2.018
|
1.144–3.560
|
0.015
|
1.920
|
1.209–3.049
|
0.006
|
NA
|
NA
|
NA
|
NA
|
NA
|
NA
|
Right sacroiliac joint
|
NA
|
NA
|
NA
|
NA
|
NA
|
NA
|
1.387
|
1.022–1.882
|
0.036
|
1.418
|
1.075–1.870
|
0.014
|